Ignite Creation Date:
2024-05-06 @ 7:52 PM
Last Modification Date:
2024-10-26 @ 3:16 PM
Study NCT ID:
NCT06169579
Status:
ENROLLING_BY_INVITATION
Last Update Posted:
2024-03-21
First Post:
2023-11-23
Brief Title:
An Open-label Phase 1 Study to Determine the Maximum Tolerated Dose of ND-003 in Patients With Advanced Solid Cancers
Sponsor:
Shenzhen NewDEL Biotech Co Ltd
Organization:
Shenzhen NewDEL Biotech Co Ltd
Key Dates - Follows AllAPIJSON File Order
Start Date:
2024-02-04
Start Date Type:
ACTUAL
Primary Completion Date:
2025-12
Primary Completion Date Type:
ESTIMATED
Completion Date:
2026-06
Completion Date Type:
ESTIMATED
First Submit Date:
2023-11-23
First Submit QC Date:
December 5 2023
Study First Post Date:
2023-12-13
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-07-15
Last Update Post Date:
2024-03-21
Last Update Post Date Type:
ACTUAL